This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Manish Mavjibhai Patel: Pharmaceutical Formulation Inventor
Introduction
Manish Mavjibhai Patel is an inventor based in Ahmedabad, India, whose patent work focuses on pharmaceutical formulations. His listed inventions address naltrexone compositions and effervescent medicines designed to limit sodium content. He is associated with Intas Pharmaceuticals Limited and has 2 patents listed in the information provided.
Latest Patents
Patel’s listed patent work includes a lactose-free, stable naltrexone formulation containing naltrexone or a pharmaceutically acceptable salt. The disclosure also describes a preparation process and potential use in treating Crohn’s disease.
Another listed invention concerns essentially sodium-free effervescent solid pharmaceutical compositions. The composition combines an active pharmaceutical ingredient with alkaline earth metal carbonates or hydrogencarbonates, pharmaceutically acceptable acids or acid salts, and suitable excipients or carriers. Its total sodium-ion content is specified as no more than 1 mmol. The disclosure also addresses preparation processes and therapeutic use.
Career Highlights
Patel’s listed inventions demonstrate work on pharmaceutical composition design and preparation. The naltrexone formulation emphasizes lactose-free stability, while the effervescent composition focuses on reducing sodium content.
Collaborations
The information provided identifies Manishkumar Jayantibhai Chauhan and Venkataramana Naidu as coworkers associated with Patel’s patent work.
Conclusion
Manish Mavjibhai Patel’s listed patent contributions center on pharmaceutical formulations, including a lactose-free naltrexone composition and an essentially sodium-free effervescent medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile